FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:APP-MMP9 (FusionGDB2 ID:5768)

Fusion Gene Summary for APP-MMP9

check button Fusion gene summary
Fusion gene informationFusion gene name: APP-MMP9
Fusion gene ID: 5768
HgeneTgene
Gene symbol

APP

MMP9

Gene ID

351

4318

Gene nameamyloid beta precursor proteinmatrix metallopeptidase 9
SynonymsAAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2|preA4CLG4B|GELB|MANDP2|MMP-9
Cytomap

21q21.3

20q13.12

Type of geneprotein-codingprotein-coding
Descriptionamyloid-beta precursor proteinalzheimer disease amyloid proteinamyloid beta (A4) precursor proteinamyloid beta A4 proteinamyloid precursor proteinbeta-amyloid peptidebeta-amyloid peptide(1-40)beta-amyloid peptide(1-42)beta-amyloid precursor proteimatrix metalloproteinase-9macrophage gelatinasematrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)type V collagenase
Modification date2020032920200329
UniProtAcc

P05067

P14780

Ensembl transtripts involved in fusion geneENST00000346798, ENST00000354192, 
ENST00000348990, ENST00000357903, 
ENST00000358918, ENST00000359726, 
ENST00000448388, ENST00000440126, 
ENST00000439274, ENST00000474136, 
ENST00000372330, 
Fusion gene scores* DoF score31 X 25 X 12=93005 X 4 X 4=80
# samples 335
** MAII scorelog2(33/9300*10)=-4.81669278663694
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(5/80*10)=-0.678071905112638
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: APP [Title/Abstract] AND MMP9 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointAPP(27264034)-MMP9(44643010), # samples:1
Anticipated loss of major functional domain due to fusion event.APP-MMP9 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneAPP

GO:0001934

positive regulation of protein phosphorylation

11404397

HgeneAPP

GO:0008285

negative regulation of cell proliferation

22944668

HgeneAPP

GO:1905606

regulation of presynapse assembly

19726636

TgeneMMP9

GO:0006508

proteolysis

2551898|15863497|19022250|24164424

TgeneMMP9

GO:0034614

cellular response to reactive oxygen species

26514923

TgeneMMP9

GO:0043388

positive regulation of DNA binding

22984561

TgeneMMP9

GO:0071276

cellular response to cadmium ion

26514923

TgeneMMP9

GO:1900122

positive regulation of receptor binding

24164424

TgeneMMP9

GO:2001258

negative regulation of cation channel activity

24164424


check buttonFusion gene breakpoints across APP (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across MMP9 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4BLCATCGA-FD-A5BX-01AAPPchr21

27264034

-MMP9chr20

44643010

+


Top

Fusion Gene ORF analysis for APP-MMP9

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000346798ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000354192ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000348990ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000357903ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000358918ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000359726ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000448388ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000440126ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
Frame-shiftENST00000439274ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+
intron-3CDSENST00000474136ENST00000372330APPchr21

27264034

-MMP9chr20

44643010

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for APP-MMP9


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)
APPchr2127264033-MMP9chr2044643009+0.00027060.99972934
APPchr2127264033-MMP9chr2044643009+0.00027060.99972934

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for APP-MMP9


check button Go to

FGviewer for the breakpoints of :-:

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
APP

P05067

MMP9

P14780

FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed:25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapes in axons (PubMed:17062754, PubMed:23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1. {ECO:0000250, ECO:0000250|UniProtKB:P12023, ECO:0000269|PubMed:17062754, ECO:0000269|PubMed:23011729, ECO:0000269|PubMed:25122912}.; FUNCTION: Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.; FUNCTION: Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain. {ECO:0000250}.; FUNCTION: The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.; FUNCTION: N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).FUNCTION: May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly-|-Leu bond. Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments. Degrades fibronectin but not laminin or Pz-peptide. {ECO:0000269|PubMed:1480034}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for APP-MMP9


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for APP-MMP9


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for APP-MMP9


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneAPPP05067DB03754TromethamineInhibitorSmall moleculeApproved
HgeneAPPP05067DB03754TromethamineInhibitorSmall moleculeApproved
HgeneAPPP05067DB03754TromethamineInhibitorSmall moleculeApproved
HgeneAPPP05067DB06782DimercaprolSmall moleculeApproved
HgeneAPPP05067DB06782DimercaprolSmall moleculeApproved
HgeneAPPP05067DB06782DimercaprolSmall moleculeApproved
HgeneAPPP05067DB09148Florbetaben (18F)BinderSmall moleculeApproved
HgeneAPPP05067DB09148Florbetaben (18F)BinderSmall moleculeApproved
HgeneAPPP05067DB09148Florbetaben (18F)BinderSmall moleculeApproved
HgeneAPPP05067DB14548Zinc sulfate, unspecified formLigandSmall moleculeApproved|Experimental
HgeneAPPP05067DB14548Zinc sulfate, unspecified formLigandSmall moleculeApproved|Experimental
HgeneAPPP05067DB14548Zinc sulfate, unspecified formLigandSmall moleculeApproved|Experimental
HgeneAPPP05067DB00746DeferoxamineSmall moleculeApproved|Investigational
HgeneAPPP05067DB00746DeferoxamineSmall moleculeApproved|Investigational
HgeneAPPP05067DB00746DeferoxamineSmall moleculeApproved|Investigational
HgeneAPPP05067DB01370AluminiumSmall moleculeApproved|Investigational
HgeneAPPP05067DB01370AluminiumSmall moleculeApproved|Investigational
HgeneAPPP05067DB01370AluminiumSmall moleculeApproved|Investigational
HgeneAPPP05067DB01593ZincCofactorSmall moleculeApproved|Investigational
HgeneAPPP05067DB01593ZincCofactorSmall moleculeApproved|Investigational
HgeneAPPP05067DB01593ZincCofactorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09130CopperAggregation inhibitorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09130CopperAggregation inhibitorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09130CopperAggregation inhibitorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09149Florbetapir (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09149Florbetapir (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09149Florbetapir (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09151Flutemetamol (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09151Flutemetamol (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09151Flutemetamol (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14517Aluminium phosphateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14517Aluminium phosphateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14517Aluminium phosphateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14518Aluminum acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14518Aluminum acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14518Aluminum acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14533Zinc chlorideLigandSmall moleculeApproved|Investigational
HgeneAPPP05067DB14533Zinc chlorideLigandSmall moleculeApproved|Investigational
HgeneAPPP05067DB14533Zinc chlorideLigandSmall moleculeApproved|Investigational
TgeneMMP9P14780DB01197CaptoprilInhibitorSmall moleculeApproved
TgeneMMP9P14780DB01197CaptoprilInhibitorSmall moleculeApproved
TgeneMMP9P14780DB14548Zinc sulfate, unspecified formBinderSmall moleculeApproved|Experimental
TgeneMMP9P14780DB14548Zinc sulfate, unspecified formBinderSmall moleculeApproved|Experimental
TgeneMMP9P14780DB01017MinocyclineInhibitorSmall moleculeApproved|Investigational
TgeneMMP9P14780DB01017MinocyclineInhibitorSmall moleculeApproved|Investigational
TgeneMMP9P14780DB01296GlucosamineAntagonistSmall moleculeApproved|Investigational
TgeneMMP9P14780DB01296GlucosamineAntagonistSmall moleculeApproved|Investigational
TgeneMMP9P14780DB01593ZincSmall moleculeApproved|Investigational
TgeneMMP9P14780DB01593ZincSmall moleculeApproved|Investigational
TgeneMMP9P14780DB14487Zinc acetateSmall moleculeApproved|Investigational
TgeneMMP9P14780DB14487Zinc acetateSmall moleculeApproved|Investigational
TgeneMMP9P14780DB14533Zinc chlorideBinderSmall moleculeApproved|Investigational
TgeneMMP9P14780DB14533Zinc chlorideBinderSmall moleculeApproved|Investigational
TgeneMMP9P14780DB00143GlutathioneSmall moleculeApproved|Investigational|Nutraceutical
TgeneMMP9P14780DB00143GlutathioneSmall moleculeApproved|Investigational|Nutraceutical

Top

Related Diseases for APP-MMP9


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneAPPC0002395Alzheimer's Disease63CTD_human;UNIPROT
HgeneAPPC0011265Presenile dementia35CTD_human
HgeneAPPC0276496Familial Alzheimer Disease (FAD)35CTD_human
HgeneAPPC0494463Alzheimer Disease, Late Onset35CTD_human
HgeneAPPC0546126Acute Confusional Senile Dementia35CTD_human
HgeneAPPC0750900Alzheimer's Disease, Focal Onset35CTD_human
HgeneAPPC0750901Alzheimer Disease, Early Onset35CTD_human
HgeneAPPC0025261Memory Disorders16CTD_human
HgeneAPPC0233794Memory impairment16CTD_human
HgeneAPPC0751292Age-Related Memory Disorders16CTD_human
HgeneAPPC0751293Memory Disorder, Semantic16CTD_human
HgeneAPPC0751294Memory Disorder, Spatial16CTD_human
HgeneAPPC0751295Memory Loss16CTD_human
HgeneAPPC0027746Nerve Degeneration11CTD_human
HgeneAPPC0023186Learning Disorders8CTD_human
HgeneAPPC0751262Adult Learning Disorders8CTD_human
HgeneAPPC0751263Learning Disturbance8CTD_human
HgeneAPPC0751265Learning Disabilities8CTD_human
HgeneAPPC1330966Developmental Academic Disorder8CTD_human
HgeneAPPC2751536CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED7CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneAPPC0009241Cognition Disorders5CTD_human
HgeneAPPC0011570Mental Depression5PSYGENET
HgeneAPPC0011581Depressive disorder5PSYGENET
HgeneAPPC0234544Todd Paralysis5CTD_human
HgeneAPPC0522224Paralysed5CTD_human
HgeneAPPC0497327Dementia3CTD_human;GENOMICS_ENGLAND
HgeneAPPC2931672Cerebral hemorrhage with amyloidosis, hereditary, Dutch type3CTD_human;ORPHANET
HgeneAPPC0270715Degenerative Diseases, Central Nervous System2CTD_human
HgeneAPPC0333463Senile Plaques2CTD_human
HgeneAPPC0524851Neurodegenerative Disorders2CTD_human
HgeneAPPC0600467Neurogenic Inflammation2CTD_human
HgeneAPPC0751733Degenerative Diseases, Spinal Cord2CTD_human
HgeneAPPC2751494CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT2CTD_human
HgeneAPPC2936349Plaque, Amyloid2CTD_human
HgeneAPPC3888307CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT2CTD_human
HgeneAPPC3888308CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT2CTD_human
HgeneAPPC3888309CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT2CTD_human
HgeneAPPC0002622Amnesia1CTD_human
HgeneAPPC0002726Amyloidosis1CTD_human
HgeneAPPC0003469Anxiety Disorders1CTD_human
HgeneAPPC0005586Bipolar Disorder1PSYGENET
HgeneAPPC0006111Brain Diseases1CTD_human
HgeneAPPC0011573Endogenous depression1PSYGENET
HgeneAPPC0016667Fragile X Syndrome1CTD_human
HgeneAPPC0023893Liver Cirrhosis, Experimental1CTD_human
HgeneAPPC0027540Necrosis1CTD_human
HgeneAPPC0033141Cardiomyopathies, Primary1CTD_human
HgeneAPPC0036529Myocardial Diseases, Secondary1CTD_human
HgeneAPPC0036572Seizures1GENOMICS_ENGLAND
HgeneAPPC0037928Spinal Cord Diseases1CTD_human
HgeneAPPC0038002Splenomegaly1CTD_human
HgeneAPPC0038454Cerebrovascular accident1GENOMICS_ENGLAND
HgeneAPPC0043094Weight Gain1CTD_human
HgeneAPPC0085220Cerebral Amyloid Angiopathy1CTD_human
HgeneAPPC0085584Encephalopathies1CTD_human
HgeneAPPC0231341Premature aging syndrome1CTD_human
HgeneAPPC0233750Hysterical amnesia1CTD_human
HgeneAPPC0233796Temporary Amnesia1CTD_human
HgeneAPPC0234985Mental deterioration1CTD_human
HgeneAPPC0236795Dissociative Amnesia1CTD_human
HgeneAPPC0262497Global Amnesia1CTD_human
HgeneAPPC0270612Leukoencephalopathy1GENOMICS_ENGLAND
HgeneAPPC0338582Sporadic Cerebral Amyloid Angiopathy1CTD_human
HgeneAPPC0338630Senile Paranoid Dementia1CTD_human
HgeneAPPC0338656Impaired cognition1CTD_human
HgeneAPPC0376280Anxiety States, Neurotic1CTD_human
HgeneAPPC0553692Brain hemorrhage1GENOMICS_ENGLAND
HgeneAPPC0750906Tactile Amnesia1CTD_human
HgeneAPPC0750907Amnestic State1CTD_human
HgeneAPPC0751071Familial Dementia1CTD_human
HgeneAPPC0751156FRAXA Syndrome1CTD_human
HgeneAPPC0751157FRAXE Syndrome1CTD_human
HgeneAPPC0878544Cardiomyopathies1CTD_human
HgeneAPPC0948008Ischemic stroke1GENOMICS_ENGLAND
HgeneAPPC1270972Mild cognitive disorder1CTD_human
HgeneAPPC1279420Anxiety neurosis (finding)1CTD_human
TgeneMMP9C0027626Neoplasm Invasiveness7CTD_human
TgeneMMP9C0027627Neoplasm Metastasis5CTD_human
TgeneMMP9C2937358Cerebral Hemorrhage5CTD_human
TgeneMMP9C0001973Alcoholic Intoxication, Chronic3PSYGENET
TgeneMMP9C0007621Neoplastic Cell Transformation3CTD_human
TgeneMMP9C0002152Alloxan Diabetes2CTD_human
TgeneMMP9C0004096Asthma2CTD_human
TgeneMMP9C0005586Bipolar Disorder2PSYGENET
TgeneMMP9C0006663Calcinosis2CTD_human
TgeneMMP9C0011853Diabetes Mellitus, Experimental2CTD_human
TgeneMMP9C0021368Inflammation2CTD_human
TgeneMMP9C0027051Myocardial Infarction2CTD_human
TgeneMMP9C0031051Pericementitis2CTD_human
TgeneMMP9C0031099Periodontitis2CTD_human
TgeneMMP9C0036341Schizophrenia2PSYGENET
TgeneMMP9C0038433Streptozotocin Diabetes2CTD_human
TgeneMMP9C0263628Tumoral calcinosis2CTD_human
TgeneMMP9C0521174Microcalcification2CTD_human
TgeneMMP9C0003486Aortic Aneurysm1CTD_human
TgeneMMP9C0003493Aortic Diseases1CTD_human
TgeneMMP9C0003496Aortic Rupture1CTD_human
TgeneMMP9C0004114Astrocytoma1CTD_human
TgeneMMP9C0005398Cholestasis, Extrahepatic1CTD_human
TgeneMMP9C0005684Malignant neoplasm of urinary bladder1CTD_human
TgeneMMP9C0005695Bladder Neoplasm1CTD_human
TgeneMMP9C0005967Bone neoplasms1CTD_human
TgeneMMP9C0006114Cerebral Edema1CTD_human
TgeneMMP9C0006142Malignant neoplasm of breast1CTD_human
TgeneMMP9C0007102Malignant tumor of colon1CTD_human
TgeneMMP9C0007114Malignant neoplasm of skin1CTD_human
TgeneMMP9C0007131Non-Small Cell Lung Carcinoma1CTD_human
TgeneMMP9C0007137Squamous cell carcinoma1CTD_human
TgeneMMP9C0007786Brain Ischemia1CTD_human
TgeneMMP9C0009324Ulcerative Colitis1CTD_human
TgeneMMP9C0009375Colonic Neoplasms1CTD_human
TgeneMMP9C0011882Diabetic Neuropathies1CTD_human
TgeneMMP9C0017636Glioblastoma1CTD_human
TgeneMMP9C0019193Hepatitis, Toxic1CTD_human
TgeneMMP9C0020507Hyperplasia1CTD_human
TgeneMMP9C0020538Hypertensive disease1CTD_human
TgeneMMP9C0023176Lead Poisoning1CTD_human
TgeneMMP9C0023893Liver Cirrhosis, Experimental1CTD_human
TgeneMMP9C0023895Liver diseases1CTD_human
TgeneMMP9C0024117Chronic Obstructive Airway Disease1CTD_human
TgeneMMP9C0024143Lupus Nephritis1CTD_human
TgeneMMP9C0024668Mammary Neoplasms, Experimental1CTD_human
TgeneMMP9C0024796Marfan Syndrome1CTD_human
TgeneMMP9C0026552Morphine Dependence1CTD_human
TgeneMMP9C0026766Multiple Organ Failure1CTD_human
TgeneMMP9C0028754Obesity1CTD_human
TgeneMMP9C0029172Oral Submucous Fibrosis1CTD_human
TgeneMMP9C0030297Pancreatic Neoplasm1CTD_human
TgeneMMP9C0033578Prostatic Neoplasms1CTD_human
TgeneMMP9C0034067Pulmonary Emphysema1CTD_human
TgeneMMP9C0034069Pulmonary Fibrosis1CTD_human
TgeneMMP9C0034189Pyemia1CTD_human
TgeneMMP9C0035126Reperfusion Injury1CTD_human
TgeneMMP9C0035309Retinal Diseases1CTD_human
TgeneMMP9C0036690Septicemia1CTD_human
TgeneMMP9C0037286Skin Neoplasms1CTD_human
TgeneMMP9C0038358Gastric ulcer1CTD_human
TgeneMMP9C0038587Substance Withdrawal Syndrome1CTD_human
TgeneMMP9C0086189Drug Withdrawal Symptoms1CTD_human
TgeneMMP9C0086565Liver Dysfunction1CTD_human
TgeneMMP9C0087169Withdrawal Symptoms1CTD_human
TgeneMMP9C0151526Premature Birth1CTD_human
TgeneMMP9C0162871Aortic Aneurysm, Abdominal1CTD_human
TgeneMMP9C0162872Aortic Aneurysm, Thoracic1CTD_human
TgeneMMP9C0205768Subependymal Giant Cell Astrocytoma1CTD_human
TgeneMMP9C0221227Centriacinar Emphysema1CTD_human
TgeneMMP9C0238281Middle Cerebral Artery Syndrome1CTD_human
TgeneMMP9C0243026Sepsis1CTD_human
TgeneMMP9C0264393Panacinar Emphysema1CTD_human
TgeneMMP9C0271673Symmetric Diabetic Proximal Motor Neuropathy1CTD_human
TgeneMMP9C0271674Asymmetric Diabetic Proximal Motor Neuropathy1CTD_human
TgeneMMP9C0271678Diabetic Mononeuropathy1CTD_human
TgeneMMP9C0271680Diabetic Polyneuropathies1CTD_human
TgeneMMP9C0271685Diabetic Amyotrophy1CTD_human
TgeneMMP9C0271686Diabetic Autonomic Neuropathy1CTD_human
TgeneMMP9C0279530Malignant Bone Neoplasm1CTD_human
TgeneMMP9C0280783Juvenile Pilocytic Astrocytoma1CTD_human
TgeneMMP9C0280785Diffuse Astrocytoma1CTD_human
TgeneMMP9C0334579Anaplastic astrocytoma1CTD_human
TgeneMMP9C0334580Protoplasmic astrocytoma1CTD_human
TgeneMMP9C0334581Gemistocytic astrocytoma1CTD_human
TgeneMMP9C0334582Fibrillary Astrocytoma1CTD_human
TgeneMMP9C0334583Pilocytic Astrocytoma1CTD_human
TgeneMMP9C0334588Giant Cell Glioblastoma1CTD_human
TgeneMMP9C0338070Childhood Cerebral Astrocytoma1CTD_human
TgeneMMP9C0340288Stable angina1CTD_human
TgeneMMP9C0340630Aortic Aneurysm, Thoracoabdominal1CTD_human
TgeneMMP9C0346647Malignant neoplasm of pancreas1CTD_human
TgeneMMP9C0376358Malignant neoplasm of prostate1CTD_human
TgeneMMP9C0393835Diabetic Asymmetric Polyneuropathy1CTD_human
TgeneMMP9C0432226Metaphyseal anadysplasia1ORPHANET
TgeneMMP9C0432291Mandibuloacral dysostosis1CTD_human
TgeneMMP9C0472387Vasogenic Cerebral Edema1CTD_human
TgeneMMP9C0472388Cytotoxic Cerebral Edema1CTD_human
TgeneMMP9C0547065Mixed oligoastrocytoma1CTD_human
TgeneMMP9C0600272Morphine Abuse1CTD_human
TgeneMMP9C0678222Breast Carcinoma1CTD_human
TgeneMMP9C0740376Middle Cerebral Artery Thrombosis1CTD_human
TgeneMMP9C0740391Middle Cerebral Artery Occlusion1CTD_human
TgeneMMP9C0740392Infarction, Middle Cerebral Artery1CTD_human
TgeneMMP9C0741160Aortic Aneurysm, Ruptured1CTD_human
TgeneMMP9C0750935Cerebral Astrocytoma1CTD_human
TgeneMMP9C0750936Intracranial Astrocytoma1CTD_human
TgeneMMP9C0750969Vasogenic Brain Edema1CTD_human
TgeneMMP9C0750970Cytotoxic Brain Edema1CTD_human
TgeneMMP9C0751074Diabetic Neuralgia1CTD_human
TgeneMMP9C0751845Middle Cerebral Artery Embolus1CTD_human
TgeneMMP9C0751846Left Middle Cerebral Artery Infarction1CTD_human
TgeneMMP9C0751847Embolic Infarction, Middle Cerebral Artery1CTD_human
TgeneMMP9C0751848Thrombotic Infarction, Middle Cerebral Artery1CTD_human
TgeneMMP9C0751849Right Middle Cerebral Artery Infarction1CTD_human
TgeneMMP9C0860207Drug-Induced Liver Disease1CTD_human
TgeneMMP9C0917798Cerebral Ischemia1CTD_human
TgeneMMP9C0948089Acute Coronary Syndrome1CTD_human
TgeneMMP9C1257931Mammary Neoplasms, Human1CTD_human
TgeneMMP9C1262760Hepatitis, Drug-Induced1CTD_human
TgeneMMP9C1458155Mammary Neoplasms1CTD_human
TgeneMMP9C1527303Chronic Airflow Obstruction1CTD_human
TgeneMMP9C1527311Brain Edema1CTD_human
TgeneMMP9C1621958Glioblastoma Multiforme1CTD_human
TgeneMMP9C1704230Grade I Astrocytoma1CTD_human
TgeneMMP9C1719672Severe Sepsis1CTD_human
TgeneMMP9C2239176Liver carcinoma1CTD_human
TgeneMMP9C2350878Focal Emphysema1CTD_human
TgeneMMP9C2751322Metaphyseal Anadysplasia 21CTD_human;GENOMICS_ENGLAND
TgeneMMP9C2936380Neointima1CTD_human
TgeneMMP9C2936381Neointima Formation1CTD_human
TgeneMMP9C3658290Drug-Induced Acute Liver Injury1CTD_human
TgeneMMP9C4277682Chemical and Drug Induced Liver Injury1CTD_human
TgeneMMP9C4279912Chemically-Induced Liver Toxicity1CTD_human
TgeneMMP9C4704874Mammary Carcinoma, Human1CTD_human
TgeneMMP9C4721507Alveolitis, Fibrosing1CTD_human
TgeneMMP9C4721845Marfan Syndrome, Type I1CTD_human